GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 188 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2018. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,430,000 | +0.7% | 65,201 | +1.3% | 0.01% | 0.0% |
| Q1 2019 | $3,405,000 | +28.9% | 64,338 | 0.0% | 0.01% | +12.5% |
| Q4 2018 | $2,641,000 | +2.8% | 64,338 | -4.9% | 0.01% | +33.3% |
| Q3 2018 | $2,570,000 | -17.9% | 67,619 | -2.4% | 0.01% | -25.0% |
| Q2 2018 | $3,131,000 | -7.0% | 69,268 | -0.6% | 0.01% | -11.1% |
| Q1 2018 | $3,367,000 | – | 69,703 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 327,905 | $17,248,000 | 9.44% |
| Asymmetry Capital Management, L.P. | 314,217 | $16,528,000 | 8.95% |
| Perceptive Advisors | 5,775,726 | $303,803,000 | 6.97% |
| NEXTHERA CAPITAL LP | 142,305 | $7,485,000 | 6.23% |
| Grace Capital | 244,914 | $12,882,000 | 6.14% |
| Broadfin Capital, LLC | 316,619 | $16,654,000 | 3.62% |
| Ghost Tree Capital, LLC | 300,000 | $15,780,000 | 3.27% |
| ArchPoint Investors | 156,635 | $8,239,000 | 2.61% |
| STANSBERRY ASSET MANAGEMENT, LLC | 114,562 | $6,026,000 | 2.37% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 13,928 | $733,000 | 2.07% |